NEW York listed QuintilesIMS has announced that it will be changing its name to IQVIA, a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients.
The company said that with the IQVIA CORE software, it is able to provide customised solutions for clients leveraging the world's largest curated healthcare information source, advanced analytics, leading technologies and extensive industry knowledge across diseases, geographies, and scientific methods.
"Today is a defining moment for our organisation as we introduce a new name that aligns with our vision to help stakeholders drive healthcare forward," said IQVIA chairman and ceo Ari Bousbib.
"Our clients have been instrumental in our becoming IQVIA," he said.
"IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years."
Bousbib added that since the merger, the company has worked to integrate its capabilities in advanced analytics, leading technologies and therapeutic expertise into powerful, differentiated offerings.
"Our vision is to outpace the inevitable progress of change across the life sciences and accelerate our ability to empower healthcare decision makers to meet the future head on."
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Nov 17